Pharmaceutical Innovation : Challenges & Competitors

Tomas E Sanchez

ISBN 10: 1622570685 / ISBN 13: 9781622570683

Published by Nova Science Publishers Inc Okt 2012, 2012

About this Item

Neuware - Congress has exhibited a strong and ongoing interest in facilitating the development of new, innovative pharmaceuticals for the marketplace while reducing the cost of drugs to consumers. Policies pertaining to funding for research and development (R&D), intellectual property protection, and co-operative ventures have played an important role in the economic success of the pharmaceutical sector. Industry-specific legislation, also work to encourage innovation in the pharmaceutical sector while facilitating the entry of lower cost generic competition. While many factors contribute to innovation in the brand pharmaceutical industry and its ability to bring new and inventive products to the marketplace, this sector is facing significant issues associated with loss of revenue for additional R&D due to patent expirations and generic competition. This book examines the challenges associated with striking the proper balance between lower cost drugs and maintaining an innovative domestic pharmaceutical sector.

Seller Inventory # 9781622570683

Bibliographic Details

• Title: Pharmaceutical Innovation : Challenges & Competitors
• Publisher: Nova Science Publishers Inc Okt 2012
• Publication Date: 2012
• Language: English
• ISBN 10: 1622570685
• ISBN 13: 9781622570683
• Binding: Buch
• Condition: Neu
• Dimensions: 238W x 167H x 15D millimeters 238 millimeters width by 167 millimeters height by 15 millimeters depth
• Weight: 364 grams

About this title

Synopsis

Congress has exhibited a strong and ongoing interest in facilitating the development of new, innovative pharmaceuticals for the marketplace while reducing the cost of drugs to consumers. Policies pertaining to funding for research and development (R&D), intellectual property protection, and co-operative ventures have played an important role in the economic success of the pharmaceutical sector. Industry-specific legislation, also work to encourage innovation in the pharmaceutical sector while facilitating the entry of lower cost generic competition. While many factors contribute to innovation in the brand pharmaceutical industry and its ability to bring new and inventive products to the marketplace, this sector is facing significant issues associated with loss of revenue for additional R&D due to patent expirations and generic competition. This book examines the challenges associated with striking the proper balance between lower cost drugs and maintaining an innovative domestic pharmaceutical sector.